Home › Funds › Soleus Capital Management, L.P. › PBLS

Soleus Capital Management, L.P. position in PBLS

PARABILIS MEDICINES INC · Health Care

Soleus Capital Management, L.P. reported holding 1,684,512 shares of PBLS (PARABILIS MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$54.4M, representing 1.93% of its reported portfolio and ranking #14 among its reported holdings. Soleus Capital Management, L.P. has disclosed PBLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.68M sh
Reported value held$54.39M
Portfolio Weight1.93%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s PBLS position evolved

Soleus Capital Management, L.P. first disclosed a stake in PBLS in Q2 2026 at 1,465,070 shares (US$40.1M). The position peaked in Q3 2026 at 1,684,512 shares, worth US$54.4M. Across 2 filings, Soleus Capital Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,684,512 shares valued at US$54.4M — an increase of 219,442 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.47M $40.10M New
Q3 2026 1.68M $54.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PBLS and 13F data

PBLS (PARABILIS MEDICINES INC) is a Health Care company. 129 other funds we track also report a position in PBLS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$942.2M), ARCH Venture Management, LLC (US$207.1M), venBio Partners LLC (US$170.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PBLS

All PBLS fund holders →

FAQ

How long has Soleus Capital Management, L.P. held PBLS?

Soleus Capital Management, L.P. has disclosed PBLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Soleus Capital Management, L.P.'s current position in PBLS?

As of Q3 2026, Soleus Capital Management, L.P. holds 1.68M shares of PBLS (PARABILIS MEDICINES INC), valued at $54.39M, representing 1.93% of its reported portfolio and ranking #14.

Has Soleus Capital Management, L.P. been buying or selling PBLS?

In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. increased its position in PBLS. The position peaked in Q3 2026 at 1.68M shares.

Which other funds hold PBLS?

Other major institutional holders of PBLS include RA CAPITAL MANAGEMENT, L.P., ARCH Venture Management, LLC, venBio Partners LLC, among 129 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.